Successful Treatment of Acquired Vulvar Lymphangiectasia with 1% Polidocanol Sclerotherapy
DOI:
https://doi.org/10.2340/00015555-3876Keywords:
lymphangiectasia, lymphangioma circumscriptum, vulva, sclerotherapy, polidocanolAbstract
Abstract is missing (Short Communication)
Downloads
References
Simon L, Trévidic P, Denis P, Vignes S. Vulvar lymphangioma circumscriptum: comparison of primary and acquired forms in a cohort of 57 patients. J Eur Acad Dermatol Venereol 2018; 32: e56–58.
Yoon G, Kim H-S, Lee Y-Y, Kim T-J, Choi C-H, Kim B-G, et al. Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum. Arch Gynecol Obstet 2016; 293: 157–162.
Makdisi J, de Feraudy S, Zachary CB. Vulvar lymphangioma circumscriptum treated with fractional ablative erbium:yttrium aluminium garnet laser. Dermatol Surg 2018; 44: 1149–1151.
AlGhamdi KM, Mubki TF. Treatment of lymphangioma circumscriptum with sclerotherapy: an ignored effective remedy. J Cosmet Dermatol 2011; 10: 156–158.
Ahn S-J, Chang S-E, Choi J-H, Moon K-C, Koh J-K, Kim D-Y. A case of unresectable lymphangioma circumscriptum of the vulva successfully treated with OK-432 in childhood. J Am Acad Dermatol 2006; 55: S106–S107.
Khunger N. Combination technique of radiofrequency ablation with sclerotherapy in acquired lymphangiectasis of the vulva. J Cutan Aesthet Surg 2009; 2: 33–35.
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
